Marshall Wace’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Marshall Wace's NVS Position: Q3 2026 in Review
Marshall Wace sold out of Novartis (NVS) in Q3 2026, closing a stake of 330,061 shares — an estimated $51.7M sold.
Marshall Wace first reported a position in NVS in Q4 2014 and held it in 25 quarters. The position peaked at $173M in Q2 2025. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Marshall Wace reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- Marshall Wace sold 330,061 Novartis shares in Q3 2026, an estimated $51.7M.
- Marshall Wace first reported a position in Novartis in Q4 2014 and held it in 25 quarters.
- Marshall Wace's Novartis position peaked at $173M in Q2 2025.
- 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.